4.5 Article

Single Application of A2 NTX, a Botulinum Toxin A2 Subunit, Prevents Chronic Pain Over Long Periods in Both Diabetic and Spinal Cord Injury-Induced Neuropathic Pain Models

Journal

JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 119, Issue 3, Pages 282-286

Publisher

JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.12080SC

Keywords

botulinum toxin type A; A2 neurotoxin (NTX); neuropathic pain

Funding

  1. Chemo-Sero Therapeutic Research Institute
  2. Grants-in-Aid for Scientific Research [24790576] Funding Source: KAKEN

Ask authors/readers for more resources

Botulinum toxin type A is a unique candidate for inhibition of pain transmission. In the present study we attempted to see the beneficial actions of A2 neurotoxin (NTX), an active subunit of botulinum toxin type A. Intraplantar injection of A2 NTX significantly suppressed mechanical allodynia and hypersensitivities to A-fiber stimuli in the diabetic neuropathic pain model. Spinal application of A2 NTX also showed a potent suppression of thermal hyperalgesia and mechanical allodynia in the spinal cord injury-induced neuropathic pain model. A2 NTX seems to be a long-lasting treatment for diabetic and spinal cord injury induced-neuropathic pain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available